Email Email Print Print
Clip Clip & File

Business & Economics :: Latest News

March 31, 2008

Genencor licenses Red/ET Recombineering tech.

Gerald Ondrey

Genencor International, Inc., a part of Danisco US Inc., has completed a commercial license agreement for the use of the Red/ET recombination technology from Gene Bridges GmbH (Heidelberg, Germany; Under the terms of the agreement, Gene Bridges has licensed the Red/ET technology to Genencor for the purpose of genetically engineering recombinant microorganisms for use in industrial applications. No financial details were disclosed.

Red/ET Recombineering is one simple and powerful tool to modify plasmids, BACs, and even E. coli chromosomes, and is said to be a revolutionary method for DNA engineering. Recombineering with Red/ET allows unlimited cloning, subcloning, and modification of DNA at any chosen position. It permits precise engineering of DNA molecules of any size, including very large ones such as BACs or the E. coli chromosome.  Recombineering DNA using Red/ET has a number of advantages over conventional methods: independent of restriction sites; no size limits; no unwanted mutations; and speed.

Add a Comment


Please enter the letters or numbers you see in the image. (refresh)

Related Stories

LinkedIn Groups

Our LinkedIn group is now over 33,000 members strong!

  1. Join other CPI professionals from all over the globe and share best practices, expertise, concerns and more.
  2. Provide feedback to Chemical Engineering Editors

Current members represent Worley Parsons, DuPont, SABIC, Fluor, Air Products, LyondellBasell, Nalco, Dow Chemical, Dow Corning, BASF, Jacobs Engineering, ExxonMobil, Shell, Chevron and more.

Join Now

We also offer the following subgroup for more targeted discussions:

Search the Buyers' Guide

Plant Cost Index

Facts at Your Fingertips (archive)

Ask the Experts

Back Issues
To access this area, please log in or create an account.
Forgot your password?
Request it now.
Live chat by BoldChat